OUR LEADERSHIP
Meet the visionary leaders behind Firefly Neuroscience. This is the dedicated team steering our pioneering efforts in brain health innovation. Their expertise and passion drive our Vision to redefine the standard of care for those navigating cognitive disorders.
- 14+ years in private equity, capital markets & merchant banking
- Advised over $1b in mergers & acquisitions
Paul Kryzwicki is a seasoned financial leader with over 15 years of experience in finance and operations. As a licensed CPA, he has served as Division Controller for a startup company, where he played a key role in driving financial strategy and growth. Paul holds a degree from Laurentian University and brings a strong background in managing complex financial operations to his role as CFO.
Gil Issachar is an accomplished technology leader with over 11 years of experience in software development, algorithm design, data science, and research. He holds a Master’s degree in Biomedical Engineering, with a thesis focused on signal processing and neuroscience. As CTO, Gil leverages his deep technical expertise to drive innovation and advance the company’s technological capabilities.
Dr. DuBraski is a sales and leadership veteran with over 20 years of experience in the medical device industry. He built his foundation at Medtronic and Covidien and transitioned into startups and disruptive technologies. He has personally been involved with launching or expanding nine different medical devices across many modalities of medicine, including Cardiology, Pulmonary, Gastroenterology, and Neuro-Psych, as well as participating in three Public Offerings.
CONTACT US
Contact Firefly Neuroscience to learn more about BNA™ or schedule a product demo. We’re here to assist and provide you with the information you need to make the best decision for your practice.